QTRX

MKT CAP:$153M

Quanterix Corporation

Market Cap

$153M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical - Devices·🇺🇸·NASDAQ

Stock Price

$3.17-$3.26 (-50.70%)

Apr 21, 2026

Company Details

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Afric...

CEO

Everett V. Cunningham

IPO Date

Dec 7, 2017

Website

www.quanterix.com

Key Metrics TTM

Revenue

$139M

+2.4% YoY

Net Income

-$107M

EPS (Diluted)

-$2.52

Free Cash Flow

-$80M

Revenue / Share

$2.97

Gross Margin

46.6%

Operating Margin

-89.9%

Net Margin

-77.2%

FCF Margin

-57.6%

P/S

1.1x

P/E

—

Earnings Reports

Q1 2026

May 11, 2026

PENDING

FY 2025

Mar 2, 2026

$139M+2.6%EPS -$2.51

Q4 2025

Mar 2, 2026

$44M+28.6%EPS -$0.49

Q3 2025

Nov 10, 2025

$40M+13.4%EPS -$0.73

Q2 2025

Aug 7, 2025

$24M-28.3%EPS -$0.77

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 21	$27M	$14M	-$15M
Q4 21	$30M	$17M	-$20M
Q1 22	$30M	$15M	-$18M
Q2 22	$23M	$9M	-$25M
Q3 22	$26M	$11M	-$37M
Q4 22	$26M	$12M	-$22M
Q1 23	$28M	$17M	-$9M
Q2 23	$31M	$19M	-$10M
Q1 24	$32M	$18M	-$15M
Q2 24	$34M	$22M	-$11M
Q3 24	$35M	$20M	-$12M
Q4 24	$34M	$21M	-$15M
Q1 25	$30M	$16M	-$26M
Q2 25	$24M	$11M	-$37M
Q3 25	$40M	$17M	-$37M
Q4 25	$44M	$20M	-$24M

Valuation

Quarter	P/S	P/E
Q3 21	1.4x	—
Q4 21	1.4x	—
Q1 22	1.4x	—
Q2 22	1.4x	—
Q3 22	1.4x	—
Q4 22	1.5x	—
Q1 23	1.5x	—
Q2 23	1.4x	—
Q1 24	1.3x	—
Q2 24	1.2x	—
Q3 24	1.2x	—
Q4 24	1.1x	—
Q1 25	1.1x	—
Q2 25	1.2x	—
Q3 25	1.2x	—
Q4 25	1.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 21	-$14M	-$18M
Q4 21	-$10M	-$13M
Q1 22	-$22M	-$23M
Q2 22	-$8M	-$13M
Q3 22	-$15M	-$18M
Q4 22	-$4M	-$6M
Q1 23	-$10M	-$10M
Q2 23	$633.0K	-$15.0K
Q1 24	-$20M	-$21M
Q2 24	-$5M	-$7M
Q3 24	-$6M	-$7M
Q4 24	-$4M	-$5M
Q1 25	-$14M	-$15M
Q2 25	-$6M	-$6M
Q3 25	-$41M	-$42M
Q4 25	-$16M	-$16M

Capital Expenditures

Quarter	CapEx
Q3 21	$4M
Q4 21	$2M
Q1 22	$1M
Q2 22	$5M
Q3 22	$4M
Q4 22	$2M
Q1 23	$136.0K
Q2 23	$648.0K
Q1 24	$506.0K
Q2 24	$2M
Q3 24	$851.0K
Q4 24	$412.0K
Q1 25	$1M
Q2 25	$777.0K
Q3 25	$677.0K
Q4 25	$98.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 21	-9.4%	+54.2%
Q4 21	+15.9%	+39.1%
Q1 22	+8.6%	+29.0%
Q2 22	-7.7%	+23.9%
Q3 22	-1.2%	+50.2%
Q4 22	-15.4%	-5.2%
Q1 23	-4.5%	-21.1%
Q2 23	+31.8%	-16.4%
Q1 24	+20.6%	-25.4%
Q2 24	+33.3%	-5.2%
Q3 24	+25.4%	+25.2%
Q4 24	+10.5%	+20.9%
Q1 25	-4.8%	+20.6%
Q2 25	-28.3%	+36.6%
Q3 25	+13.4%	+64.3%
Q4 25	+28.6%	+38.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 21	$4M	15.0%
Q4 21	$0	0.0%
Q1 22	$0	0.0%
Q2 22	$5M	22.1%
Q3 22	$3M	10.5%
Q4 22	$4M	14.3%
Q1 23	$4M	13.8%
Q2 23	$4M	13.6%
Q1 24	$0	0.0%
Q2 24	$0	0.0%
Q3 24	$0	0.0%
Q4 24	$0	0.0%
Q1 25	$5M	18.0%
Q2 25	$5M	22.0%
Q3 25	$0	0.0%
Q4 25	$4M	10.1%

OpEx Breakdown

Quarter	R&D	G&A
Q3 21	$7M	$24M
Q4 21	$8M	—
Q1 22	$7M	$26M
Q2 22	$7M	$27M
Q3 22	$7M	$21M
Q4 22	$6M	$20M
Q1 23	$5M	$22M
Q2 23	$6M	$23M
Q1 24	$7M	$27M
Q2 24	$8M	$25M
Q3 24	$8M	$24M
Q4 24	$8M	$29M
Q1 25	$10M	$33M
Q2 25	$9M	$32M
Q3 25	$8M	$39M
Q4 25	$9M	$35M

Revenue Segments

Quarter	License and Service	Product	Service And Other Revenue
Q4 25	$152.0K	$29M	$14M

Revenue by Geography

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$374M	$0	$374M
Q2 22	$361M	$0	$361M
Q3 22	$344M	$0	$344M
Q4 22	$339M	$0	$339M
Q1 23	$329M	$0	$329M
Q2 23	$330M	$0	$330M
Q3 23	$201M	$126M	$328M
Q4 23	$174M	$147M	$321M
Q1 24	$45M	$257M	$302M
Q2 24	$47M	$250M	$297M
Q3 24	$29M	$264M	$294M
Q4 24	$57M	$232M	$289M
Q1 25	$77M	$190M	$267M
Q2 25	$133M	$128M	$261M
Q3 25	$38M	$97M	$135M
Q4 25	$30M	$88M	$118M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 21	37M	+0.5%	+16.3%
Q4 21	37M	+0.5%	+15.8%
Q1 22	37M	+0.4%	+7.0%
Q2 22	37M	+0.2%	+1.6%
Q3 22	37M	+0.2%	+1.3%
Q4 22	37M	+0.4%	+1.3%
Q1 23	37M	+0.4%	+1.3%
Q2 23	37M	+0.4%	+1.5%
Q1 24	38M	+1.7%	+3.0%
Q2 24	38M	+0.6%	+3.2%
Q3 24	38M	+0.3%	+3.0%
Q4 24	39M	+0.3%	+2.8%
Q1 25	39M	+0.4%	+1.6%
Q2 25	39M	+0.5%	+1.4%
Q3 25	46M	+18.4%	+19.8%
Q4 25	47M	+1.6%	+21.3%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 21	$85.0K	314
Q4 21	$65.8K	460
Q1 22	$64.2K	460
Q2 22	$50.9K	460
Q3 22	$57.3K	460
Q4 22	$204.9K	125
Q1 23	$225.9K	125
Q2 23	$247.0K	125
Q1 24	$225.5K	141
Q2 24	$242.0K	141
Q3 24	$251.1K	141
Q4 24	$72.4K	471
Q1 25	$64.3K	471
Q2 25	$51.9K	471
Q3 25	$85.2K	471
Q4 25	$97.5K	450

Revenue / Employee